Frontlight ResearchEarly access
Trial site
Erie Retina Research LLC
- 5running trials
- 5closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Macular degeneration6 trials
- Diabetic eye disease2 trials
- Retinitis pigmentosa1 trial
- Phase
- Phase 24 trials
- Phase 12 trials
- Phase 32 trials
- Phase 2/31 trial
- Status
- Completed4 trials
- Active, not recruiting3 trials
- Recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Ocugen3 trials
- Annexon, Inc.1 trial
- Aviceda Therapeutics, Inc.1 trial
- Boehringer Ingelheim1 trial
- Cognition Therapeutics1 trial
- and 3 more
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa
Recruiting
Active, not recruiting
A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Diabetic eye disease1 recruiting
- Macular degeneration1 recruiting
Closed trials
Completed
Completed
Terminated
Completed
Completed
Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration (i-SIGHT)
Site data: ClinicalTrials.govUpdated 18 Nov 2026